We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$362M
AUM Growth
+$17.5M
Cap. Flow
-$3.53M
Cap. Flow %
-0.98%
Top 10 Hldgs %
26.51%
Holding
183
New
15
Increased
37
Reduced
60
Closed
3

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$8.08M
2
WSM icon
Williams-Sonoma
WSM
+$5.93M
3
NOW icon
ServiceNow
NOW
+$5.7M
4
DGX icon
Quest Diagnostics
DGX
+$5.22M
5
CSCO icon
Cisco
CSCO
+$283K

Sector Composition

Rank Sector Weight
1 Technology 18.13%
2 Healthcare 17.26%
3 Industrials 12.91%
4 Financials 11.41%
5 Consumer Discretionary 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
26
Alphabet (Google) Class A
GOOGL
$4.34T
$5.1M 1.41%
84,540
+360
+0.4% +$21.8K
NSC icon
27
Norfolk Southern
NSC
$76.1B
$5.07M 1.4%
28,059
-150
-0.5% -$25.6K
GS icon
28
Goldman Sachs
GS
$303B
$4.79M 1.32%
21,362
+255
+1% +$59.3K
SUPN icon
29
Supernus Pharmaceuticals
SUPN
$2.71B
$4.46M 1.23%
88,515
+685
+0.8% +$33.8K
BABA icon
30
Alibaba
BABA
$305B
$4.39M 1.21%
26,618
-350
-1% -$61.9K
BMY icon
31
Bristol-Myers Squibb
BMY
$131B
$3.86M 1.07%
62,141
-1,425
-2% -$84.6K
ICUI icon
32
ICU Medical
ICUI
$4.63B
$3.75M 1.04%
13,270
-740
-5% -$217K
CSCO icon
33
Cisco
CSCO
$473B
$3.58M 0.99%
73,547
+6,300
+9% +$283K
ED icon
34
Consolidated Edison
ED
$39.7B
$3.26M 0.9%
42,730
-250
-0.6% -$19.7K
PEP icon
35
PepsiCo
PEP
$189B
$2.88M 0.8%
25,777
-75
-0.3% -$8.49K
BRK.B icon
36
Berkshire Hathaway Class B
BRK.B
$1.12T
$2.82M 0.78%
13,155
+940
+8% +$193K
LLY icon
37
Eli Lilly
LLY
$1.06T
$2.79M 0.77%
26,035
+200
+0.8% +$20K
TFC icon
38
Truist Financial
TFC
$64.3B
$2.75M 0.76%
56,598
-661
-1% -$33.9K
SO icon
39
Southern Company
SO
$107B
$2.74M 0.76%
62,839
-1,000
-2% -$46.1K
NFLX icon
40
Netflix
NFLX
$308B
$2.72M 0.75%
72,600
-8,600
-11% -$312K
VZ icon
41
Verizon
VZ
$194B
$2.56M 0.71%
47,910
+2,144
+5% +$113K
T icon
42
AT&T
T
$163B
$2.54M 0.7%
100,006
-1,816
-2% -$44.5K
D icon
43
Dominion Energy
D
$58.9B
$2.44M 0.67%
34,697
-700
-2% -$49.6K
AGN
44
DELISTED
Allergan plc
AGN
$2.4M 0.66%
12,585
+1,525
+14% +$280K
DD icon
45
DuPont de Nemours
DD
$19.6B
$2.36M 0.65%
14,513
+375
+3% +$64.5K
INTC icon
46
Intel
INTC
$502B
$2.34M 0.65%
49,531
-109,185
-69% -$5.31M
VWO icon
47
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$2.3M 0.64%
56,044
-775
-1% -$32.6K
CVX icon
48
Chevron
CVX
$367B
$2.18M 0.6%
17,835
-100
-0.6% -$12.1K
RGCO icon
49
RGC Resources
RGCO
$228M
$2.15M 0.6%
80,577
ZTS icon
50
Zoetis
ZTS
$31.6B
$2.14M 0.59%
23,390
+300
+1% +$26.6K

Similar funds

Dixon Hubard Feinour & Brown's Q3 2018 Portfolio in Review

As of Q3 2018, Dixon Hubard Feinour & Brown held 183 positions worth $362M, up 5.1% from $344M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2018 filing shows 15 new, 37 increased, 60 reduced and 3 closed positions. Its largest new stake was Thermo Fisher Scientific: 35,115 shares worth $8.57M. The largest sale was Meta Platforms (Facebook), an estimated $9.45M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Dixon Hubard Feinour & Brown's largest Q3 2018 buy was Thermo Fisher Scientific: 35,115 shares worth $8.57M.
  • Dixon Hubard Feinour & Brown added most to Cisco in Q3 2018, an estimated $283K increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2018 reduction was State Street SPDR S&P Regional Banking ETF, cutting an estimated $8.93M.
  • Dixon Hubard Feinour & Brown fully exited Meta Platforms (Facebook) in Q3 2018, selling an estimated $9.45M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 27% of its $362M portfolio in Q3 2018.
  • Dixon Hubard Feinour & Brown opened 15 new positions and closed 3 in Q3 2018.
  • Dixon Hubard Feinour & Brown's portfolio value rose 5.1% quarter-over-quarter to $362M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2018, filed 6 Nov 2018.